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Abstract
Background: Identifying the molecular interactions using bioinformatics tools before venturing into wet lab
studies saves the energy and time considerably. The present study summarizes, molecular interactions and binding
energy calculations made for major structural protein, collagen of Type I and Type III with the chosen cross-linkers,
namely, coenzyme Q10, dopaquinone, embelin, embelin complex-1 & 2, idebenone, 5-O-methyl embelin, potassium
embelate and vilangin.
Results: Molecular descriptive analyses suggest, dopaquinone, embelin, idebenone, 5-O-methyl embelin, and
potassium embelate display nil violations. And results of docking analyses revealed, best affinity for Type I (- 4.74 kcal/
mol) and type III (-4.94 kcal/mol) collagen was with dopaquinone.
Conclusions: Among the selected cross-linkers, dopaquinone, embelin, potassium embelate and 5-O-methyl
embelin were the suitable cross-linkers for both Type I and Type III collagen and stabilizes the collagen at the
expected level.
Background
Collagen is the most abundant fibrillar protein in multicel-
lular animals and the protein of importance for current
scenario on development of tissue engineering materials
for therapeutic applications. It has unique protein motif
containing three super-coiled polyproline II helices with
high percentage of imino acids. Thus, it contains repeating
units of Gly-Xaa-Yaa, where, proline and 4-hydroxyproline
occupy Xaa and Yaa positions respectively. Almost all pro-
lines in the Yaa position of vertebrate collagen post-trans-
lationally modified to hydroxyproline in the presence of
enzyme (prolyl-4-hydroxylase). Ever since the report of tri-
ple helical structure of collagen by Ramachandran and
Kartha [1] nearly fifty years ago, there has been a consider-
able interest in the study of molecular properties and
structure of the collagen. Molecular modeling of collagen
has a long fascinating history, as Miller and Scheraga [2]
reported computational model of collagen, especially eval-
uate the effects of specific side chains on conformation.
Later Chen et al. [3] performed molecular docking to form
a microfibril template based on the smith model [4]. Piez
and Truzs [5] constructed three-dimensional energy-mini-
mized model for calf-skin type-I collagen. Qi et al. [6] con-
structed the N-terminal te1opeptides model.
Cross linking of collagen is often necessary to improve
the stability as well as resistance against enzymatic degra-
dation. The existing cross linking agents such as formalde-
hyde, glutaraldehyde and epoxy compounds are all
identified as cytotoxic, which limits the clinical applica-
tions and provokes scientific community to look for alter-
native natural cross linking/stabilizing agents. In addition,
awareness on collagen modification and fibril coating in
tanning has recently gained interest among Leather Che-
mist’s. Ramasami [7] reported interaction of the collagen
with small molecules like water, polyphenols and chro-
mium (III) salt. Wu et al. [8] observed covalent interac-
tions between glutaraldehyde and collagen. With regard to
quinone tannage, Thomas and Kelly [9] reported, effect of
pH on quinone fixation by collagen [9]. Stecker and High-
berger [10] observed, nature of the buffer system plays an
important role in collagen-quinone reactions. Theis [11]
reported, collagen upon treatment with quinone, an appre-
ciable increase in shrinkage temperature ultimately
increased the structural strength of the collagen due to the
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tion of the reactive centers of quinone with amino groups
in juxtaposition.
With regard to the bioinformatics on cross-linking
chemistry of collagen, only very few reports are available
collagen with polyphenols [12], and with alginic acid [13].
In order to select the suitable cross-linkers for the pre-
paration of collagen based biomaterials, in the present
study we made an attempt on bioinformatics in cross link-
ing of selected cross linkers coenzyme Q10, dopaquinone,
embelin, embelin complex-1 & 2, idebenone, 5-O-methyl
embelin, potassium embelate (unless otherwise mentioned
without potassium metal) and vilangin with collagen of
both Type I and Type III. Since most of the selected
cross-linkers are of from natural sources, the results of the
study will find application in wet lab conditions.
Methods
Protein preparation
Restricting the number of repeating units is necessary in
the modeling and simulation of a large macromolecule
like collagen. In the present study, 24-mer collagen triple
helix was constructed by Object Technology Framework
(OTF) using the GENCOLLAGEN package [14]. The 24-
residue long triple helix constructed corresponds to the
residues 193 to 216 (2a1a n d1 a2 chains) of the native
type I collagen except residue 204 of the a1c h a i n ,w h e r e
Ala of native collagen was replaced by lysine in order to
study the interaction of ligands with the side chains of
basic amino acids. In case of type III collagen, all the three
are identically a 1chains (3 a 1chains).
Ligand preparation
Chemical structures of ligands such as embelin [CID no:
3218], vilangin [CID no: 417182], coenzyme Q10 [CID no:
5281915], idebenone [CID No: 3686], potassium embelate
[CID no: 23677950], 5-O-methyl embelin [CID no:
171489] and dopaquinone [CID no: 439316] were
retrieved from Pubchem compound database [15]. Una-
vailable three dimensional structures such as embelin
complex-1 & 2 were generated using ACD/ChemSketch
[16].
Docking setup
Docking was performed using Autodock 4. Autodock
combines energy evaluation through precalculated grids of
affinity potential employing various search algorithms to
find the suitable binding position for a ligand on a given
protein [17]. Kollman unit e da t o mc h a r g e sa n dp o l a r
hydrogens were added to the protein PDB using Autodock
tools [17]. All rotatable bonds in the ligands were kept
free to allow for flexible docking. Grid size was set to 40 ×
40 × 40 grid points (x, y and z), with spacing between grid
points kept at 0.375 Å. The Lamarckian genetic algorithm
was chosen to search for the best conformers. Standard
docking protocol was applied. One hundred independent
docking runs were carried out for each ligand was gener-
ated by using genetic algorithm searches.
Molecular descriptors calculation
Quantitative structure-activity relationships (QSARs)
correlate the response with molecular properties of com-
pounds under interest. Any compound to be considered
as a lead must possess acceptable scores for all of the
descriptors. Molinspiration [18] was used to calculate
thirteen descriptors such as logP, polar surface area,
molecular weight, number of atoms, number of O or N,
number of OH or NH, number of rotatable bonds,
volume, drug likeness (includes GPCR ligand, ion chan-
nel modulator, kinase inhibitor and nuclear receptor
ligand) and number of violations to Lipinski’s rule for all
ligands taken for the analysis [19].
Results and discussion
Molecular Physicochemical and the Drug-Likeness are
the two properties that are important for considering a
compound to become a successful drug. Table 1 depicts
the International Union of Pure and Applied Chemistry
(IUPAC) name and Simplified Molecular Input Line
Entry Specification (SMILES) of ligands. Two dimen-
sional structure of dopaquinone, embelin, potassium
embelate and 5-O-methyl embelin also represented in
additional files 1, 2, 3 and 4. A chemical nomenclature
is a set of rules followed to generate systematic names
for chemical compounds. IUPAC nomenclature is a uni-
versal chemical nomenclature. It is developed and kept
up to date under the auspices of the International
Union of Pure and Applied Chemistry (IUPAC). The
simplified molecular input line entry specification
(SMILES) is a specification for unambiguously describ-
ing the structure of chemical molecules using short
ASCII strings. SMILES strings can be imported by most
molecule editors for conversion back into two-dimen-
sional drawings or three-dimensional models of the
molecules.
The rule formulated by Christopher A. Lipinski et al.
[20] considered as the thumb rule thumb rule to evalu-
ate drug likeness, or determine if a chemical compound
with a certain pharmacological or biological activity has
properties that would make it a likely orally active drug
in humans. The rule describes molecular properties
important for a drug’s pharmacokinetics in the human
body, including their absorption, distribution, metabo-
lism, and excretion ("ADME”). The rule is important for
drug development where a pharmacologically active lead
structure is optimized step-wise for increased activity
and selectivity, as well as drug-like properties as
described by Lipinski’s rule.
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Page 2 of 8Table 1 Ligand Molecules - IUPAC Name and SMILES
Ligand IUPAC Name SMILES
Coenzyme Q
10
2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)- 3,7,11,15,19,23,27,31,35,39-decamethyltetraconta-
2,6,10,14,18,22,26,30,34,38-decaenyl]-5, 6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione
CC1=C(C(=O)C(=C(C1=O)OC)OC)CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C
(C)CCC=C (C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C
Dopaquinone (2S)-2-amino-3-(3,4-dioxocyclohexa-1,5-dien-1-yl)propanoic acid C1=CC(=O)C(=O)C=C1CC(C(=O)O)N
Embelin 2,5-dihydroxy-3-undecylcyclohexa-2,5-diene-1,4-dione CCCCCCCCCCCC1=C(C(=O)C=C(C1=O)O)O
Embelin
complex-1
Not available O=C2C(CCCCCCCCCCC)=C(O)C([OH+][OH+][OH+][OH+]C=1C(CCCCCCCCCCC)
=C(O)C(=O)CC=1O)=CC2O
Embelin
complex-2
Not available O=C2C=C(O)C(=O)C(CCCCCCCCCCC)=C2OO[N+](/[O-])=[O+]\[O+](OC1=CC
(=O)C(O)=C(CCCCCCCCCCC)C1=O)[N+]([O-])=O
Idebenone 2-(10-hydroxydecyl)-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione CC1=C(C(=O)C(=C(C1=O)OC)OC)CCCCCCCCCCO
5-O-Methyl
embelin
2-hydroxy-5-methoxy-3-undecylcyclohexa-2,5-diene-1,4-dione CCCCCCCCCCCC1=C(C(=O)C=C(C1=O)OC)O
Potassium
embelate
6-hydroxy-3,4-dioxo-5-undecylcyclohexa-1,5-dien-1-olate CCCCCCCCCCCC1=C(C(=CC(=O)C1=O)[O-])O
Vilangin 2-[(2,5-dihydroxy-3,6-dioxo-4-undecylcyclohexa-1,4-dien-1-yl)methyl]-3, 6-dihydroxy-5-undecylcyclohexa-
2,5-diene-1,4-dione
CCCCCCCCCCCC1=C(C(=O)C(=C(C1=O)O)CC2=C(C(=O)C(=C(C2=O)O)
CCCCCCCCCCC)O)O
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8LogP (Octanol-water partition coefficient) is used as
important tool in both quantitative structure-activity rela-
tionship (QSAR) studies and rational drug design as a
measure of molecular hydrophobicity. Hydrophobicity
affects drug absorption, bioavailability, hydrophobic drug-
receptor interactions, metabolism of molecules, as well as
their toxicity. LogP has become a key parameter in studies
of the environmental fate of chemicals. In the present
study LogP value of dopaquinone was -2.684, which indi-
cates more hydrophilic nature, whereas LogP value of
coenzyme Q 10 was 10.509, indicates more lipophilic or
hydrophobic nature. On other hand potassium embelate,
idebenone, embelin and 5-O-methyl embelin demon-
strated LogP value between 2.2-4.8 as shown in Table-2.
LogP value less than 5 will be preferred for drug likeness
property.
The preferred range of molecular weight for drug like-
ness property was 160-480 g/mol as reported by Tambu-
nan and Wulandari [21]. The molecular weight of the
selected cross-linkers was calculated as 195.17 g/mol
(dopaquinone), 293.38 g/mol (potassium embelate), 294.39
g/mol (embelin), was 308.41 g/mol (5-O-methyl embelin)
and 338.44 g/mol (idebenone). With regard to the pre-
ferred number of N, O (hydrogen bond acceptors) and
OH & NH (hydrogen bond donors) 10 and or less than 10
and 5 and or less than 5 respectively compliance with the
rule. From table 2, it has been observed that embelin com-
plex-2 showed greater than 10 with respect to N and O,
whereas the embelin complex-1 showed greater than 5
with respect to OH and NH. Further, the preferred num-
ber of rotatable bonds (rotb) is 15 and or less than 15, and
we observed that it was greater than 15 for the cross lin-
kers vilangin, embelin complex-1, embelin complex-2 and
coenzyme Q 10 (Table 2). The preferred number of Viola-
tions is 0, and we observed nil violations for the dopaqui-
none, embelin, idebenone, 5-O-methyl embelin, and
potassium embelate and suggest all the five chosen ligands
satisfy well with thumb rule (Table-2).
With regard to affinity and binding energy calculations,
each chosen ligands displayed different affinities with the
collagen types (I & III). Lead ‘1’ dopaquinone alone showed
the best affinity with both the type-I & III collagen (-4.74
kcal/mol and -4.94 kcal/mol) followed by potassium embe-
late, embelin, and 5-O-methyl embelin for type I collagen
(Table 3 & Figure 1). However, with type III collagen, fol-
lowed by dopaquinone, embelin showed the second best
affinity, which was followed by potassium embelate.
With regard to the interaction sites, bond sites and
bond distance, calculated based on the bioinformatics
tool for the cross-linking between collagen (Type I) and
four ligands (four lead molecules) as shown in table 4,
emphasizes, the first lead molecule ‘dopaquinone’ inter-
acts with collagen (Type I) through non-polar aminoacids
(Proline and Valine) and polar aminoacid (Lysine and
Asparagine). Second lead molecule ‘potassium embelate’
interacts with collagen (Type I) through non-polar ami-
noacid (Valine). Third lead molecule ‘embelin’ interacts
with collagen (Type I) through non-polar aminoacids
(Proline, Glycine and Valine). Fourth lead molecule ‘5-O-
methyl embelin’ interacts with collagen (Type I) through
non-polar aminoacids (Proline and Valine) and polar
aminoacid (Tyrosine).
And with reference to type III collagen, the interaction
sites, bond sites and bond distance, calculated based on
the bioinformatics tool for the cross-linking of four
ligands (four lead molecules) Table 5 emphasizes, the
first lead molecule ‘dopaquinone’ interacts with collagen
(Type III) through non-polar aminoacids (Proline and
Alanine) and polar aminoacid (Lysine). Second lead
molecule ‘embelin’ interacts with collagen (Type III)
through non-polar aminoacid( G l y c i n e )a n dp o l a ra m i -
noacid (Lysine). Third lead molecule ‘potassium embe-
late’ interacts with collagen (Type III) through non-
polar aminoacids (Proline and Glycine). Fourth lead
molecule ‘5-O-methyl embelin’ interacts with collagen
(Type III) through non-polar aminoacids (Proline) and
polar aminoacid (Lysine).
The reason behind the choice of quinone based com-
pounds is described below. Meunier and Seyewetz [22]
identified the remarkable stabilizing (tanning) potential
of p-benzoquinone and after them it has been named as
quinone tannage. Later, Thomas and Kelly [9] compre-
hensively investigated the stabilization of collagen by
quinone. Wilson [23] reported benzoquinone tans/stabi-
lizes well in alcoholic solution, and well correlated with
many aspects of formaldehyde tannage. Theis [11]
reported collagen treated with quinone has increased
shrinkage temperature and the structural strength. Later
Suparno [24] reported two salient features of quinone-
tannage; viz., an increase in shrinkage temperature (Ts)
(> 90°C) and high resistant to the proteolytic degrada-
tion. Further, Covington [25] also reported increase in
shrinkage temperature upon treating collagen with qui-
none alone; however, he said the toxicity has to be con-
sidered before going for commercial use.
With regard to molecular interaction studies using
bioinformatics tools, Vaidyanathan et al [26] studied the
interactions of five ligands (2-Hydroxyethyl methacrylate
(HEMA), Glutaraldehyde-HEMA adduct, Glyceryl
dimethacrylate, Methacryloyloxyethyl maleate and Acry-
loyloxyethyl citraconate) with collagen and reported that
steric and electrostatic complementarity interactions
form the potential basis of binding between dentin
adhesive ligands and type 1 collagen. Madhan et al. [27]
studied stabilization of collagen by catechin, reported on
the interactions of a catechin with 24-mer collagen
triple helix through hydrogen bonding interaction. Mitra
et al. [13] studied, thermal stabilization of collagen by
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Page 4 of 8Table 2 The descriptor analysis helped in the identification of the better ligand
Coenzyme Q
10
Dopaquinone Embelin Embelin
complex-1
Embelin
complex-2
Idebenone 5-O-Methyl
embelin
Potassium embelate
without K
Vilangin
Molecular Physicochemical properties
Logp (Octanol-water partition coefficient) 10.509 -2.684 4.617 4.753 5.413 4.197 4.893 2.247 9.248
TPSA (Polar surface area) 52.61 97.464 74.598 172.374 227.469 72.838 63.604 77.427 149.196
No. of atoms(Number of nonhydrogen atoms) 63 14 21 44 50 24 22 21 43
M.wt (Molecular weight) 863.365 195.174 294.391 626.828 710.774 338.444 308.418 293.383 600.793
No. of ON (Number of hydrogen-bond acceptors [O
and N atoms])
454 1 01 65 4 4 8
No. of OHNH (Number of hydrogen-bond donors [OH
and NH groups])
032 8 2 1 1 1 4
No. of Violations (Number of Rule of 5 violations) 2 0 0 2 3 0 0 0 2
No. of rotb (Number of rotatable bonds) 31 3 10 25 27 12 11 10 22
Volume (Molecular volume) 937.819 166.513 295.208 617.365 651.349 338.282 312.736 292.466 594.584
Drug likeness
GPCR ligand -3.37 -0.21 -0.42 -0.49 -1.18 -0.22 -0.41 -0.14 -0.34
Ion channel modulator -4.35 0.05 -0.34 -1.39 -2.47 -0.33 -0.39 -0.08 -1.07
Kinase inhibitor -3.93 -0.84 -0.05 -0.88 -1.55 -0.21 -0.05 -0.16 -0.51
Nulcear receptor ligand -4.04 -0.58 -0.36 -0.73 -1.83 -0.17 -0.36 -0.07 -0.52
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8Table 5 Interaction sites, bond sites and bond distance, between collagen (Type III) and four ligands
Ligand Interaction sites Bond Bond distance in(A°)
Collagen type-III
Dopaquinone Eleventh residue Val of B-chain (a1) Val B 12(Ca)-O· · ·N(Dopaquinone) 2.6
Eleventh residue Val of B-chain (a1) Val B 12(Ca)-O· · ·O(Dopaquinone) 2.83
Fourteenth residue Pro of B-chain (a1) Pro B 14(Ca)-N· · ·O(Dopaquinone) 2.97
Fifteenth residue Ala of B-chain (a1) Asn B 15(Ca)-N· · ·O(Dopaquinone) 3.02
Embelin Eleventh residue Lys of B-chain (a1) Lys B 12(Ca)-N· · ·O(Embelin) 3.02
Thirteenth residue Gly of B-chain (a1) Gly B 13(Ca)-O· · ·O(Embelin) 2.72
Potassium embelate Thirteenth residue Gly of B-chain (a1) Gly B 13(Ca)-O· · ·O(Potassium embelate) 2.62
Fourteenth residue Pro of B-chain (a1) Pro C 14(Ca)-N· · ·O(Potassium embelate) 2.98
5-O-Methyl embelin Eleventh residue Lys of C-chain (a1) Lys C 12(Ca)-O· · ·O(5-O-Methyl embelin) 2.72
Fourteenth residue Pro of C-chain (a2) Pro C 14(Ca)-O· · ·O(5-O-Methyl embelin) 3.45
Table 3 The binding energy helped in the identification of the better ligand
Coenzyme
Q1 0
Dopaquinone Embelin Embelin
complex-1
Embelin
complex-2
Idebenone 5-O-
Methyl
embelin
Potassium
embelate
without K
Vilangin
Docking results
Type I collagen-Lowest
binding energy(kcal/mol)
0.79 -4.74 -3.6 -0.28 0.04 -3.33 -3.55 -3.78 -0.34
Type I collagen-Mean
binding energy(kcal/mol)
15.69 -4.54 -3.1 0.18 0.77 -2.6 -2.82 -3.08 32.99
Type III collagen-Lowest
binding energy(kcal/mol)
0.11 -4.94 -3.56 0.27 0.44 -2.93 -3.21 -3.23 1.26
Type III collagen-Mean
binding energy(kcal/mol)
16.42 -4.71 -2.87 0.77 1.29 -2.42 -2.87 -2.87 11.74
a                            b                           c                     d 
e                           f                             g                     h 
 
Type-III 
Type-I 
Figure 1 Docking results of the four lead molecules namely dopaquinone, embelin, potassium embelate and 5-O-methyl embelin.
[Where a-e (docking results of the four lead molecules namely dopaquinone, embelin, potassium embelate and 5-O-methyl embelin) with type I
collagen. Where f-i (docking results of the four lead molecules namely dopaquinone, embelin, potassium embelate and 5-O-methyl embelin)
with type III collagen].
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Page 6 of 8alginic acid and reported on the interactions of alginic
acid with 24-mer collagen triple helix through hydrogen
bonding interaction with binding energy of -7.28 kcal/
mol.
Conclusion
Present study provides the molecular interaction view of
quinones with both type I collagen and type III collagen,
as a first eye opener on quinone and collagen interac-
tions using bioinformatics tool. Out of nine quinone
studied, dopaquinone, potassium embelate, embelin and
5-O-methyl embelin showed better affinities with both
type I collagen and type III collagen. Hence dopa qui-
none, embelin, potassium embelate and 5-O-methyl
embelin could be developed as potential cross-linking/
stabilization agent of collagen preparation and found
application as wound dressing sheet in clinical
applications.
Additional material
Additional file 1: 2D structure of dopaquinone. Figure represents the
two dimensional structure of dopaquinone.
Additional file 2: 2D structure of embelin. Figure represents the two
dimensional structure of embelin.
Additional file 3: 2D structure of potassium embelate. Figure
represents the two dimensional structure of potassium embelate.
Additional file 4: 2D structure of 5-O-methyl embelin. Figure
represents the two dimensional structure of 5-O-methyl embelin.
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